icon-folder.gif   Conference Reports for NATAP  
 
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
 
 
 
SPIRIT: Simplifying to Rilpivirine/Emtricitabine/Tenofovir DF Single-Tablet Regimen from Boosted Protease Inhibitor Regimen Maintains HIV Suppression in the Black Subgroup Week 48 Results
 
 
  Reported by Jules Levin
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
September 10-13, 2013Denver, CO, USA
 
K Mounzer1, F Palella2, J Slim3, C Dietz4, J Flamm5, P Ruane6, R Ebrahimi7, D Porter7, K Patel7, V Scharen-Guivel7, S De-Oertel7, T Fralich7 1Philadelphia FIGHT; Philadelphia, PA; 2Feinberg School of Medicine, Northwestern Univ., Chicago, IL; 3Saint Michael's Medical Center, Newark, NJ; 4Kansas City Free Health Clinic, Kansas City, MO; 5Kaiser Permanente, Sacramento, CA; 6Peter J Ruane, MD, Inc., Los Angeles, CA; 7Gilead Sciences, Inc., Foster City, CA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif

ICAAC11.gif

ICAAC12.gif

ICAAC13.gif

ICAAC14.gif